Seeing Is Believing
Currently out of the existing stock ratings of Jason Kolbert, 126 are a BUY (86.9%), 16 are a HOLD (11.03%), 3 are a SELL (2.07%).
Analyst Jason Kolbert, currently employed at BENCHMARK, carries an average stock price target met ratio of 56.55% that have a potential upside of 56.35% achieved within 487 days.
Jason Kolbert’s has documented 244 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AVXL, Anavex Life Sciences Corp at 31-Oct-2024.
Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for PSTI (PLURISTEM) at 2/10/2020. The price target of $12 was fulfilled within 74 days with a profit of $8.38 (231.49%) receiving and performance score of 31.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4 years 5 months 23 days ago
(13-May-2020)
0/2 (0%)
$7.2 (167.00%)
Hold
4 years 11 months 10 days ago
(26-Nov-2019)
0/1 (0%)
$1.7 (32.08%)
Which stock is Jason Kolbert is most bullish on?
Which stock is Jason Kolbert is most reserved on?
What Year was the first public recommendation made by Jason Kolbert?